and/or

42 Trending Topics found

Memorial Sloan Kettering Cancer Center Endorses HPV Vaccination for Cancer Prevention

MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated cancer centers across the country, calls upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer. MSK head and neck and gynecologic cancer experts are available to discuss the importance of the HPV vaccine and risks of HPV-related cancers. Please email mediastaff@mskcc.org to arrange an interview.

  • Wednesday, January 27, 2016

MSK Experts Weigh in on Mammography Debate

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at mcnamarn@mskcc.org.

  • Monday, January 11, 2016

Exciting New Research Presented at 2016 ASCO Genitourinary Cancers Symposium

MSK experts are available to comment on research presented at the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium including exciting new findings from Howard Scher, MD, Chief of the Genitourinary Oncology Service, about the potential of liquid biopsies to help guide prostate cancer treatment decisions. For more information on MSK's research at the meeting and to set up interviews, email Nicole McNamara at mcnamarn@mskcc.org.

  • Tuesday, January 5, 2016

2015 San Antonio Breast Cancer Meeting: Liquid Biopsies and More

The newest breast cancer research will be presented at the 2015 San Antonio Breast Cancer Symposium, taking place from December 8 to 12. MSK researchers will present research in the meeting's press program about liquid biopsies and are available to discuss other studies presented at the meeting, including research on experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease. For more information and to set up interviews, email Caitlin Hool at hoolc@mskcc.org.

  • Wednesday, December 9, 2015

Major Developments in Hematology-Oncology to Be Reported at ASH Annual Meeting

The largest hematology-oncology meeting in the world will take place in Orlando, Florida from December 5 through 8. Memorial Sloan Kettering experts are available to comment on breaking news out of the meeting. For more information and to set up interviews or access photos and video, email Rebecca Williams, williamr@mskcc.org.

  • Thursday, December 3, 2015

A Better Way to Measure Cancer Survival Outcomes Among US Hospitals?

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. Now, a new MSK study in JAMA Oncology explores a potential way to profile US hospitals by performance so, eventually, patients can make more informed decisions about their care. For more information and to set up interviews, email Jeanne D’Agostino at DAgostiJ@mskcc.org.

  • Thursday, October 8, 2015

First-Ever Combination Immunotherapy Receives Approval by the FDA

The US Food and Drug Administration approved the immunotherapy combination nivolumab (Opdivo®) plus ipilimumab (Yervoy®) for use in patients with metastatic melanoma. Memorial Sloan Kettering’s medical oncologist and cancer immunologist Jedd Wolchok, created and tested the combination and led the clinical trials that resulted in FDA approval. Patients who have received this new drug combination are also available for interview. For more information and to set up interviews, email Nicole McNamara at mcnamarn@mskcc.org.

  • Thursday, October 1, 2015

New Research Presented at 2015 European Cancer Congress Meeting

Memorial Sloan Kettering experts are available to comment on research presented at the 2015 European Cancer Congress, including research in immunotherapy, breast, lung, bladder, prostate, and kidney cancers, among others. For more information and to set up interviews or access photos and video, email Rebecca Williams, williamr@mskcc.org.

  • Thursday, September 24, 2015

Exciting New Research at the 2015 ASCO meeting

MSK experts are available to comment on research presented at the 2015 annual meeting of the American Society of Clinical Oncology, including exciting new findings on how immunotherapy is helping patients with many cancers. For more information on MSK's research at the meeting and to set up interviews or access photos and video, email Caitlin Hool at hoolc@mskcc.org.

  • Thursday, May 28, 2015

Promising New Research at the 2015 AACR Annual Meeting

Memorial Sloan Kettering experts are available to comment on the exciting new research presented at the 2015 American Association of Cancer Research annual meeting, including research in immunotherapy in pediatric cancers and melanoma, breast cancer, and many others. For more information and to set up interviews or access photos and video, email Rebecca Williams at williamr@mskcc.org.

  • Saturday, April 18, 2015